http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05009626-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eae0df72e352bf35416d265d202bf0ac
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465
filingDate 2004-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0fff48f54e2bd80ea613b4a4d8f629b
publicationDate 2005-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-PA05009626-A
titleOfInvention SUBCUTANEOUS LIBERATION SYSTEM, ITS PREPARATION AND USE PROCESS FOR THE TREATMENT OF COLINERGIC DEFICIENCY DISORDERS.
abstract The present invention relates to a subcutaneous delivery system comprising a biodegradable polymer matrix and at least one of the pharmacologically active substances of the general Formula (I) (see General Formula (I)): wherein the residue A represents a amino group -NH2 or an ammonium group -NH3 + or a residue of the general Formula (II) (see General Formula (II)): where each of X1 to X5 independently represents a hydrogen atom, a group linear or branched C1 to C6 alkyl, a linear or branched C1 to C6 alkyloxy group, a hydroxyl group -OH, an amino-NH2 group, a primary or secondary C1 to C6 alkylamino group, a halogen atom, a nitro -NO2 group ; This substance is included in this matrix. The invention relates to a process for its preparation and its use for the preparation of a medicament.
priorityDate 2003-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564

Total number of triples: 34.